linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth

Get access to free reads

Start Your Trial Start Your membership

Get 15-day free trial to all of ET Prime

Start Your Trial Start Your membership
Not a member
Already a member?
Not a member

Your membership

RENEW

R&D

1
R&D

Superbugs have designs on India. Our preparation is inadequate.

Anti-microbial resistance (AMR) is a threat that is growing in severity. The country needs to develop better tests for early diagnosis, educate patients and doctors to not overuse antibiotics, and invest in new-generation antibiotics. At the moment, it is doing too little in all three areas.

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]